FDA Limits J&J Vaccine Over Blood Clot Risk

The U.S. Food and Drug Administration (FDA) is restricting the use of the Johnson & Johnson vaccine due to the risk of blood clots. The FDA is also investigating reports of viral relapses following the use of Pfizer’s COVID-19 pill.

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.